Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M42.4Revenue $M1.0Net Margin (%)-172.9Z-Score29.8
Enterprise Value $M37.2EPS $-0.0Operating Margin %-172.9F-Score2
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-172.9Higher ROA y-yN
Price/Book7.510-y EBITDA Growth Rate %13.7Quick Ratio4.5Cash flow > EarningsN
Price/Sales37.45-y EBITDA Growth Rate %-15.8Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-26.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-32.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M52.7ROI % (ttm)-52.3Gross Margin Increase y-yN

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 56.

No Entry found!

IGXT is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Zerbe Horst GDirector 2014-01-31Sell250,000$0.92-27.17 view
Zerbe IngridCorporate Secretary 2014-01-31Sell250,000$0.92-27.17 view
BluMont Capital Corp10% Owner 2012-11-09Buy70,000$0.670 view
BluMont Capital Corp10% Owner 2012-10-11Buy205,000$0.661.52 view
BluMont Capital Corp10% Owner 2012-09-19Buy145,000$0.611.67 view
BluMont Capital Corp10% Owner 2012-09-07Buy92,000$0.611.67 view
BluMont Capital Corp10% Owner 2012-08-15Buy170,000$0.5619.64 view
BluMont Capital Corp10% Owner 2012-07-11Buy84,345$0.5326.42 view
BluMont Capital Corp10% Owner 2012-06-18Buy80,000$0.5424.07 view
BluMont Capital Corp10% Owner 2012-05-10Buy125,000$0.534 view

Press Releases about IGXT :

    Quarterly/Annual Reports about IGXT:

      News about IGXT:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      INTELGENX TECHNOLOGIES CORP. Financials Jul 08 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 10-Q/A, Quarterly Report Jul 02 2014
      2014-07-01 IntelGenx Announces Equity Analyst Coverage by H.C. Wainwright Jul 02 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jul 01 2014
      IntelGenx Announces Equity Analyst Coverage by H.C. Wainwright Jul 01 2014
      Coverage initiated on IntelGenx by H.C. Wainwright Jun 30 2014
      IntelGenx: A Compelling Investment Opportunity Jun 27 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events May 21 2014
      RedHill Biopharma, IntelGenx report positive RHB-103 study results May 21 2014
      IntelGenx and RedHill Biopharma Report Positive Bioavailability Study Results in Support of Planned... May 21 2014
      RedHill Biopharma and IntelGenx Report Positive RHB-103 Bioavailability Study Results in Support of... May 21 2014
      IntelGenx Reports Q1 2014 Results and Provides Corporate Development Update May 13 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 10-Q, Quarterly Report May 13 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 08 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Apr 30 2014
      IntelGenx Announces Government of Canada Funding for CNS VersaFilm(TM) Project Apr 30 2014
      INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Apr 28 2014
      IntelGenx and RedHill Biopharma Announce Commencement of a Bioavailability Study With Anti-Migraine... Apr 28 2014
      RedHill Biopharma and IntelGenx Announce Commencement of a Bioavailability Study With RHB-103... Apr 28 2014
      2014-04-24 IntelGenx and RedHill Biopharma Provide an Update on FDA's Ongoing Review of the NDA for... Apr 24 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide